z-logo
open-access-imgOpen Access
Effects of cyclin E gene silencing on the proliferation of esophageal cancer cell lines, EC9706, Eca109 and KYSE30
Author(s) -
Na Wang,
Min Li,
Wenqiao Zang,
Yunyun Ma,
Yuanyuan Wang,
Guoqiang Zhao
Publication year - 2013
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2013.1280
Subject(s) - cell cycle , transfection , microbiology and biotechnology , biology , gene silencing , cell growth , cyclin e , cyclin b1 , cyclin b , cyclin d1 , oncogene , cyclin , cyclin a , flow cytometry , cyclin d , apoptosis , cancer research , cell culture , gene , cyclin dependent kinase 1 , genetics
In order to observe the effects of cyclin E gene silencing by small interferingRNA (siRNA) on the growth, proliferation, invasion and apoptosis of esophagealcancer cell lines, including EC9706, Eca109 and KYSE30, siRNA vectors targetingcyclin E gene were constructed and then transfected into the EC9706, Eca109 andKYSE30 human esophageal cancer cell lines. Cyclin E mRNA and protein expressionwere determined by RT-PCR and western blotting. Cell proliferation and clonalitywere detected using a CCK-8 test and soft agar colony formation assay. Cell cycledistribution, apoptosis and invasion of EC9706, Eca109 and KYSE30 cells were evaluatedwith flow cytometry and a transwell culture system. After siRNA vectors targetingthe cyclin E gene were transfected into EC9706, Eca109 and KYSE30 cell lines,compared with blank and negative control groups, the expression of cyclin E mRNAand protein (P<0.01), colony-forming units and the number of cells penetratingthe transwell membrane (P<0.05) were significantly decreased, the cells inthe S and G2/M phase were reduced, the cells in the G0/G1 phase were increasedand the apoptosis rate was increased (P<0.01) in the experimental groups. Cyclin Egene silencing effectively inhibits growth, proliferation and invasion of esophagealcancer cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here